Butts CA, Socinski MA, Mitchell P, et al. START: A phase III study of L -BLP25 (Tecemotide) cancer immunotherapy for unresectable stage III non -small cell lung cancer. Journal of clinical oncology : official journal of the Am erican Society of Clinical Oncology 2013;31:abstr 7500.